JP Morgan Chase
CGEM icon

JP Morgan Chase’s Cullinan Oncology CGEM Stock Holding History

JP Morgan Chase’s Portfolio CGEM Stock Details CGEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.99M Buy
297,231
+150,176
+102% +$1.93M ﹤0.01% 3532
2025
Q4 		$1.52M Buy
147,055
+115,187
+361% +$1.04M ﹤0.01% 4311
2025
Q3 		$189K Sell
31,868
-65,201
-67% -$477K ﹤0.01% 5549
2025
Q2 		$731K Buy
97,069
+53,522
+123% +$430K ﹤0.01% 4567
2025
Q1 		$330K Sell
43,547
-154,667
-78% -$1.48M ﹤0.01% 5019
2024
Q4 		$2.41M Buy
198,214
+169,104
+581% +$2.43M ﹤0.01% 4003
2024
Q3 		$487K Buy
29,110
+5,842
+25% +$104K ﹤0.01% 4911
2024
Q2 		$406K Buy
23,268
+3,798
+20% +$80.9K ﹤0.01% 4798
2024
Q1 		$332K Sell
19,470
-5,723
-23% -$88.4K ﹤0.01% 5051
2023
Q4 		$257K Buy
25,193
+879
+4% +$7.79K ﹤0.01% 5228
2023
Q3 		$220K Buy
24,314
+3,635
+18% +$37.9K ﹤0.01% 5015
2023
Q2 		$223K Sell
20,679
-1,564
-7% -$16.6K ﹤0.01% 5014
2023
Q1 		$228K Buy
22,243
+2,858
+15% +$31.5K ﹤0.01% 4986
2022
Q4 		$205K Sell
19,385
-524
-3% -$6.37K ﹤0.01% 5028
2022
Q3 		$256K Buy
19,909
+1,914
+11% +$25.8K ﹤0.01% 4826
2022
Q2 		$231K Sell
17,995
-6,177
-26% -$70K ﹤0.01% 5000
2022
Q1 		$253K Buy
24,172
+4,115
+21% +$55.6K ﹤0.01% 5066
2021
Q4 		$309K Buy
20,057
+4,918
+32% +$98.1K ﹤0.01% 5116
2021
Q3 		$341K Buy
15,139
+7,015
+86% +$188K ﹤0.01% 4938
2021
Q2 		$209K Sell
8,124
-30,077
-79% -$925K ﹤0.01% 5225
2021
Q1 		$1.59M Buy
+38,201
New +$1.55M ﹤0.01% 3883

Other funds holding CGEM

LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.58B AUM 138.67% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $369M AUM 78.25% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return